Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

Clinical trial NCT04377048 · UNKNOWN

Trial details

NCT number: NCT04377048
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Pancreatic Cancer

Start date: 2020-07-01
Primary completion: 2022-07-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.